Key result
Platelet factor 4 inhibits endothelial cell proliferation and angiogenesis with potential implications for cardiovascular disease.
Why the study?
The mechanisms and potential cardiovascular roles of platelet factor 4 (PF4) as an antiangiogenic chemokine require comprehensive review to inform therapeutic development.
Comparison
PF4 and its fragments with antiangiogenic properties
Design
Review
Authors
Loading...
Hypothesis-generating for PF4-based antiangiogenic strategies in neovascular cardiovascular disease; leaves open clinical translation pending prospective trials.
PF4 and its fragments exhibit antiangiogenic properties through multiple mechanisms, offering potential therapeutic leads for cardiovascular diseases involving neovascularization.
Andréas Bikfalvi (2004) conducted a review in Cardiovascular disease. Platelet factor 4 (PF4) was evaluated. Platelet factor 4 is an antiangiogenic chemokine that inhibits endothelial cell proliferation and angiogenesis through multiple mechanisms, with potential implications for cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: